Spex Capital launches €100m fund for early stage healthtech ventures

Digital health and med-tech investment firm Spex Capital has launched a new fund with a target size of €100m. The Spex Venture HealthTech Fund is a closed-end fund which will invest globally in early-stage healthtech ventures, from seed to Series A, up to €5m. Spex, which was founded in 2021 by serial health tech entrepreneur Claudio D’Angelo,…